Novavax (NVAX) Files Requesting Provisional Approval of its COVID-19 Vaccine in Australia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. SPY
5. ACN
6. IBM
7. META
8. PFE
9. TSLA
10. DPZ

Go back to Novavax (NVAX) Files Requesting Provisional Approval of its COVID-19 Vaccine in Australia
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.23 +0.23 (2.56%)
Previous Close $9.00    52 Week High $9.23 
Open $8.81    52 Week Low $1.16 
Day High $9.59    P/E N/A 
Day Low $8.81    EPS $-0.30 
Volume 2,589,789